YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Cadila Healthcare

Cadila Healthcare

BSE: 532321|NSE: CADILAHC|ISIN: INE010B01027|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Feb 26, 13:14
436.90
-0.9 (-0.21%)
VOLUME 121,194
LIVE
NSE
Feb 26, 13:14
437.10
-0.95 (-0.22%)
VOLUME 2,198,511
News on Cadila Healthcare
Select Year: 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
USFDA begins inspections of Indian manufacturing sites deemed mission-critical

12.37 pm | 25 Feb 2021 |  Source: Moneycontrol.com

Inspections of sites deemed to be mission critical for the US resumed last month. The American drug regulator’s India director Christopher Middendor...

Cadila Healthcare share price gains over 2% on USFDA final approval

12.30 pm | 25 Feb 2021 |  Source: Moneycontrol.com

The share touched its 52-week high of Rs 509.35 on January 15, 2021 and a 52-week low of Rs 212.70 on March 13, 2020....

Zydus Cadila's US subsidiary acquires experimental drug from Cyprium for treating Menkes disease

8.16 pm | 24 Feb 2021 |  Source: Moneycontrol.com

Under the terms of the agreement, Sentynl will make $20 million in upfront development and regulatory cash milestones through New Drug Application...

Indian pharma firms go local seeking to end reliance on China

5.45 pm | 23 Feb 2021 |  Source: Reuters

Though India is known as the pharmacy of the world for its massive production capacities of both generic drugs and vaccines, China accounted for half ...

Cadila Healthcare stock trades lower even after USFDA nod for blood pressure drug

11.39 am | 19 Feb 2021 |  Source: Moneycontrol.com

The drug will be manufactured at the group’s formulation facility in Ahmedabad....

Buy Cadila Healthcare; target of Rs 550: Motilal Oswal

4.04 pm | 12 Feb 2021 |  Source: Moneycontrol.com

Motilal Oswal is bullish on Cadila Healthcare has recommended buy rating on the stock with a target price of Rs 550 in its research report dated Febru...

Buy Cadila Healthcare; target of Rs 555: ICICI Direct

3.30 pm | 10 Feb 2021 |  Source: Moneycontrol.com

ICICI Direct is bullish on Cadila Healthcare has recommended buy rating on the stock with a target price of Rs 555 in its research report dated Februa...

Zydus Cadila says it has more orders for COVID-19 vaccine than it can make

5.08 pm | 08 Feb 2021 |  Source: Moneycontrol.com

The company has completed Phase–1 and 2 trials, and began work on its Phase-3 trial, for which it plans to recruit around 30,000 volunteers across 6...

Cadila Healthcare Q3 net profit up 41% to Rs 527 crore

3.40 pm | 05 Feb 2021 |  Source: PTI

The company had posted a net profit of Rs 373.9 crore for the corresponding period of the previous fiscal, Cadila Healthcare said in a filing to BSE....

Cadila Health Consolidated December 2020 Net Sales at Rs 3,795.60 crore, up 4.33% Y-o-Y

2.22 pm | 05 Feb 2021 |  Source: Moneycontrol.com

NULL...

Cadila Health Consolidated December 2020 Net Sales at Rs 3,795.60 crore, up 4.33% Y-o-Y

2.22 pm | 05 Feb 2021 |  Source: Moneycontrol.com

NULL...

Cadila Health Standalone December 2020 Net Sales at Rs 1,918.80 crore, up 12.14% Y-o-Y

2.22 pm | 05 Feb 2021 |  Source: Moneycontrol.com

NULL...

Buy Cadila Healthcare; target of Rs 655: Emkay Global Financial

5.01 pm | 25 Jan 2021 |  Source: Moneycontrol.com

Emkay Global Financial is bullish on Cadila Healthcare has recommended buy rating on the stock with a target price of Rs 655 in its research report da...

Zydus Cadila says 'positive results' from phase 2 studies of COVID-19 drug Desidustat in Mexico

10.57 am | 25 Jan 2021 |  Source: PTI

In June 2020, Zydus Cadila had received approval from Mexico's regulatory authority Cofepris to test one of its lead research candidate Desidustat...

Status check on COVID-19 vaccines in pipeline for India over next six months

8.44 pm | 20 Jan 2021 |  Source: Moneycontrol.com

In the initial phase, India will inoculate about one crore healthcare workers. This will be followed by two crore frontline workers, police, armed for...

Cadila Healthcare Q3 PAT seen up 37.6% YoY to Rs. 373.9 cr: Prabhudas Lilladher

10.52 pm | 18 Jan 2021 |  Source: Moneycontrol.com

Net Sales are expected to increase by 5.3 percent Y-o-Y (up 0.3 percent Q-o-Q) to Rs. 3,638.1 crore, according to Prabhudas Lilladher....

Accumulate Cadila Healthcare; target of Rs 497: Dolat Capital Market

6.54 pm | 07 Nov 2020 |  Source: Moneycontrol.com

Dolat Capital Market recommended accumulate rating on Cadila Healthcare with a target price of Rs 497 in its research report dated November 02, 2020....

Buy Cadila Healthcare; target of Rs 555: ICICI Direct

1.41 pm | 07 Nov 2020 |  Source: Moneycontrol.com

ICICI Direct is bullish on Cadila Healthcare has recommended buy rating on the stock with a target price of Rs 555 in its research report dated Novemb...

Sell Cadila Healthcare; target of Rs 357: Prabhudas Lilladher

4.45 pm | 06 Nov 2020 |  Source: Moneycontrol.com

Prabhudas Lilladher is bearish on Cadila Healthcare has recommended sell rating on the stock with a target price of Rs 357 in its research report date...

Buy Cadila Healthcare: target of Rs 530: Sharekhan

5.07 pm | 05 Nov 2020 |  Source: Moneycontrol.com

Sharekhan is bullish on Cadila Healthcare recommended buy rating on the stock with a target price of Rs 530 in its research report dated November 03, ...

1 2
Quick Links for Cadila Healthcare
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.